Allopurinol versus Febuxostat: A new approach for the management of hepatic steatosis in metabolic dysfunction-associated steatotic liver disease

Al-Shargi, Amani; Adel, Abdulmoneim; Hassany, Mohamed; Shaheen, Sara M; Elkholy, Amal;

Other data

Title Allopurinol versus Febuxostat: A new approach for the management of hepatic steatosis in metabolic dysfunction-associated steatotic liver disease
Authors Al-Shargi, Amani; Adel, Abdulmoneim; Hassany, Mohamed; Shaheen, Sara M; Elkholy, Amal 
Issue Date 2023
Publisher MDPI
Journal Biomedicines
Volume 11
Issue 11
Start page 3074

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.